Email: atrayee.bhattacharya@uttyler.edu
Department: Cellular and Molecular Biology
Atrayee Bhattacharya
Dr. Atrayee Bhattacharya is a molecular and cancer biologist whose research focuses
on chromatin remodeling and epigenetic mechanisms that drive therapy resistance in
aggressive cancers. At the University of Texas at Tyler School of Medicine, she leads
a
research program investigating how oncogenic signaling pathways reprogram enhancer
landscapes and transcriptional networks to sustain cancer stemness and tumor
plasticity in lung cancer, triple-negative breast cancer, and glioblastoma. Before
joining
UTT School of Medicine, she completed postdoctoral training and served as an
Instructor at Dana-Farber Cancer Institute and Harvard Medical School, where she
defined the role of the MUC1-C oncoprotein in coordinating inflammatory signaling
and
chromatin remodeling in advanced malignancies.
Education and Training
• PhD, Biomedical Sciences, University of North Dakota School of Medicine and
Health Sciences
• Postdoctoral Fellowship, Dana-Farber Cancer Institute, Harvard Medical
School
• MS, Applied Microbiology, Banaras Hindu University
• BS, Microbiology, University of North Bengal
Academic Appointments
• Assistant Professor, University of Texas at Tyler School of Medicine at the University
of Texas at Tyler Health Science Center.
• Instructor, Dana-Farber Cancer Institute, Harvard Medical School
• Postdoctoral Research Fellow, Dana-Farber Cancer Institute, Harvard Medical School
Research Interests
- Epigenetic and chromatin remodeling mechanisms underlying therapy resistance in
solid tumors. - Next-generation sequencing–based genomic and epigenomic profiling of enhancer
reprogramming and transcriptional networks. - Cancer stem cell plasticity and inflammatory signaling programs that sustain tumor
progression. - Translational targeting of MUC1-C in lung cancer, triple-negative breast cancer, and
glioblastoma.